COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2026

COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type
1.4.2 Iodinated Contrast Media
1.4.3 Barium-Based Contrast Media
1.4.4 Microbubble Contrast Media
1.4.5 Other
1.5 Market by Application
1.5.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application
1.5.2 Heart Disease
1.5.3 Neurological
1.5.4 Urology
1.5.5 General Surgery
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Interventional X-ray Contrast and Imaging Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Interventional X-ray Contrast and Imaging Agents Industry
1.6.1.1 Interventional X-ray Contrast and Imaging Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Interventional X-ray Contrast and Imaging Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Interventional X-ray Contrast and Imaging Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Estimates and Forecasts
2.1.1 Global Interventional X-ray Contrast and Imaging Agents Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Interventional X-ray Contrast and Imaging Agents Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Interventional X-ray Contrast and Imaging Agents Production Estimates and Forecasts 2015-2026
2.2 Global Interventional X-ray Contrast and Imaging Agents Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Interventional X-ray Contrast and Imaging Agents Manufacturers Geographical Distribution
2.4 Key Trends for Interventional X-ray Contrast and Imaging Agents Markets & Products
2.5 Primary Interviews with Key Interventional X-ray Contrast and Imaging Agents Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Production Capacity
3.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Production (2015-2020)
3.1.3 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers Market Share by Production
3.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue
3.2.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2019
3.3 Global Interventional X-ray Contrast and Imaging Agents Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Interventional X-ray Contrast and Imaging Agents Production by Regions
4.1 Global Interventional X-ray Contrast and Imaging Agents Historic Market Facts & Figures by Regions
4.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Production (2015-2020)
4.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
4.2.2 North America Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
4.3.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
4.4 China
4.4.1 China Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
4.4.2 China Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
4.5.2 Japan Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
5 Interventional X-ray Contrast and Imaging Agents Consumption by Region
5.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Consumption
5.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Consumption (2015-2020)
5.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Interventional X-ray Contrast and Imaging Agents Consumption by Application
5.2.2 North America Interventional X-ray Contrast and Imaging Agents Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Application
5.3.2 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption by Application
5.4.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Interventional X-ray Contrast and Imaging Agents Consumption by Application
5.5.2 Central & South America Interventional X-ray Contrast and Imaging Agents Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption by Application
5.6.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Interventional X-ray Contrast and Imaging Agents Market Size by Type (2015-2020)
6.1.1 Global Interventional X-ray Contrast and Imaging Agents Production by Type (2015-2020)
6.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2015-2020)
6.1.3 Interventional X-ray Contrast and Imaging Agents Price by Type (2015-2020)
6.2 Global Interventional X-ray Contrast and Imaging Agents Market Forecast by Type (2021-2026)
6.2.1 Global Interventional X-ray Contrast and Imaging Agents Production Forecast by Type (2021-2026)
6.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Type (2021-2026)
6.2.3 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2021-2026)
6.3 Global Interventional X-ray Contrast and Imaging Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Bracco
8.1.1 Bracco Corporation Information
8.1.2 Bracco Overview and Its Total Revenue
8.1.3 Bracco Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Bracco Product Description
8.1.5 Bracco Recent Development
8.2 General Electric
8.2.1 General Electric Corporation Information
8.2.2 General Electric Overview and Its Total Revenue
8.2.3 General Electric Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 General Electric Product Description
8.2.5 General Electric Recent Development
8.3 Guerbet
8.3.1 Guerbet Corporation Information
8.3.2 Guerbet Overview and Its Total Revenue
8.3.3 Guerbet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Guerbet Product Description
8.3.5 Guerbet Recent Development
8.4 Fujifilm Visualsonics
8.4.1 Fujifilm Visualsonics Corporation Information
8.4.2 Fujifilm Visualsonics Overview and Its Total Revenue
8.4.3 Fujifilm Visualsonics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Fujifilm Visualsonics Product Description
8.4.5 Fujifilm Visualsonics Recent Development
8.5 Imax
8.5.1 Imax Corporation Information
8.5.2 Imax Overview and Its Total Revenue
8.5.3 Imax Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Imax Product Description
8.5.5 Imax Recent Development
8.6 J.B. Chemicals & Pharmaceuticals
8.6.1 J.B. Chemicals & Pharmaceuticals Corporation Information
8.6.2 J.B. Chemicals & Pharmaceuticals Overview and Its Total Revenue
8.6.3 J.B. Chemicals & Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 J.B. Chemicals & Pharmaceuticals Product Description
8.6.5 J.B. Chemicals & Pharmaceuticals Recent Development
8.7 Jodas Expoim
8.7.1 Jodas Expoim Corporation Information
8.7.2 Jodas Expoim Overview and Its Total Revenue
8.7.3 Jodas Expoim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Jodas Expoim Product Description
8.7.5 Jodas Expoim Recent Development
8.8 Lantheus Medical Imaging
8.8.1 Lantheus Medical Imaging Corporation Information
8.8.2 Lantheus Medical Imaging Overview and Its Total Revenue
8.8.3 Lantheus Medical Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Lantheus Medical Imaging Product Description
8.8.5 Lantheus Medical Imaging Recent Development
8.9 Nano Therapeutics
8.9.1 Nano Therapeutics Corporation Information
8.9.2 Nano Therapeutics Overview and Its Total Revenue
8.9.3 Nano Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Nano Therapeutics Product Description
8.9.5 Nano Therapeutics Recent Development
8.10 Novalek Pharmaceuticals
8.10.1 Novalek Pharmaceuticals Corporation Information
8.10.2 Novalek Pharmaceuticals Overview and Its Total Revenue
8.10.3 Novalek Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Novalek Pharmaceuticals Product Description
8.10.5 Novalek Pharmaceuticals Recent Development
8.11 Taejoon Pharm
8.11.1 Taejoon Pharm Corporation Information
8.11.2 Taejoon Pharm Overview and Its Total Revenue
8.11.3 Taejoon Pharm Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Taejoon Pharm Product Description
8.11.5 Taejoon Pharm Recent Development
8.12 Unijules Life Sciences
8.12.1 Unijules Life Sciences Corporation Information
8.12.2 Unijules Life Sciences Overview and Its Total Revenue
8.12.3 Unijules Life Sciences Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Unijules Life Sciences Product Description
8.12.5 Unijules Life Sciences Recent Development
9 Production Forecasts by Regions
9.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions Forecast by Revenue (2021-2026)
9.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions Forecast by Production (2021-2026)
9.3 Key Interventional X-ray Contrast and Imaging Agents Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region
10.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
10.2 North America Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
10.3 Europe Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
10.5 Latin America Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
11.2.2 Interventional X-ray Contrast and Imaging Agents Distributors
11.3 Interventional X-ray Contrast and Imaging Agents Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Interventional X-ray Contrast and Imaging Agents Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Interventional X-ray Contrast and Imaging Agents Key Market Segments in This Study
Table 2. Ranking of Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type 2020-2026 (K MT) (Million US$)
Table 4. Major Manufacturers of Iodinated Contrast Media
Table 5. Major Manufacturers of Barium-Based Contrast Media
Table 6. Major Manufacturers of Microbubble Contrast Media
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Interventional X-ray Contrast and Imaging Agents Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Interventional X-ray Contrast and Imaging Agents Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Interventional X-ray Contrast and Imaging Agents Players to Combat Covid-19 Impact
Table 13. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Interventional X-ray Contrast and Imaging Agents Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Interventional X-ray Contrast and Imaging Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional X-ray Contrast and Imaging Agents as of 2019)
Table 17. Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Interventional X-ray Contrast and Imaging Agents Product Offered
Table 19. Date of Manufacturers Enter into Interventional X-ray Contrast and Imaging Agents Market
Table 20. Key Trends for Interventional X-ray Contrast and Imaging Agents Markets & Products
Table 21. Main Points Interviewed from Key Interventional X-ray Contrast and Imaging Agents Players
Table 22. Global Interventional X-ray Contrast and Imaging Agents Production Capacity by Manufacturers (2015-2020) (K MT)
Table 23. Global Interventional X-ray Contrast and Imaging Agents Production Share by Manufacturers (2015-2020)
Table 24. Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Interventional X-ray Contrast and Imaging Agents Revenue Share by Manufacturers (2015-2020)
Table 26. Interventional X-ray Contrast and Imaging Agents Price by Manufacturers 2015-2020 (USD/MT)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Interventional X-ray Contrast and Imaging Agents Production by Regions (2015-2020) (K MT)
Table 29. Global Interventional X-ray Contrast and Imaging Agents Production Market Share by Regions (2015-2020)
Table 30. Global Interventional X-ray Contrast and Imaging Agents Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Regions (2015-2020)
Table 32. Key Interventional X-ray Contrast and Imaging Agents Players in North America
Table 33. Import & Export of Interventional X-ray Contrast and Imaging Agents in North America (K MT)
Table 34. Key Interventional X-ray Contrast and Imaging Agents Players in Europe
Table 35. Import & Export of Interventional X-ray Contrast and Imaging Agents in Europe (K MT)
Table 36. Key Interventional X-ray Contrast and Imaging Agents Players in China
Table 37. Import & Export of Interventional X-ray Contrast and Imaging Agents in China (K MT)
Table 38. Key Interventional X-ray Contrast and Imaging Agents Players in Japan
Table 39. Import & Export of Interventional X-ray Contrast and Imaging Agents in Japan (K MT)
Table 40. Global Interventional X-ray Contrast and Imaging Agents Consumption by Regions (2015-2020) (K MT)
Table 41. Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Regions (2015-2020)
Table 42. North America Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 43. North America Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2015-2020) (K MT)
Table 44. Europe Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 45. Europe Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2015-2020) (K MT)
Table 46. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 47. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application (2015-2020) (K MT)
Table 48. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption by Regions (2015-2020) (K MT)
Table 49. Latin America Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 50. Latin America Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2015-2020) (K MT)
Table 51. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 52. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2015-2020) (K MT)
Table 53. Global Interventional X-ray Contrast and Imaging Agents Production by Type (2015-2020) (K MT)
Table 54. Global Interventional X-ray Contrast and Imaging Agents Production Share by Type (2015-2020)
Table 55. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2015-2020) (Million US$)
Table 56. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2015-2020)
Table 57. Interventional X-ray Contrast and Imaging Agents Price by Type 2015-2020 (USD/MT)
Table 58. Global Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 59. Global Interventional X-ray Contrast and Imaging Agents Consumption by Application (2015-2020) (K MT)
Table 60. Global Interventional X-ray Contrast and Imaging Agents Consumption Share by Application (2015-2020)
Table 61. Bracco Corporation Information
Table 62. Bracco Description and Major Businesses
Table 63. Bracco Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 64. Bracco Product
Table 65. Bracco Recent Development
Table 66. General Electric Corporation Information
Table 67. General Electric Description and Major Businesses
Table 68. General Electric Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 69. General Electric Product
Table 70. General Electric Recent Development
Table 71. Guerbet Corporation Information
Table 72. Guerbet Description and Major Businesses
Table 73. Guerbet Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Guerbet Product
Table 75. Guerbet Recent Development
Table 76. Fujifilm Visualsonics Corporation Information
Table 77. Fujifilm Visualsonics Description and Major Businesses
Table 78. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Fujifilm Visualsonics Product
Table 80. Fujifilm Visualsonics Recent Development
Table 81. Imax Corporation Information
Table 82. Imax Description and Major Businesses
Table 83. Imax Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Imax Product
Table 85. Imax Recent Development
Table 86. J.B. Chemicals & Pharmaceuticals Corporation Information
Table 87. J.B. Chemicals & Pharmaceuticals Description and Major Businesses
Table 88. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. J.B. Chemicals & Pharmaceuticals Product
Table 90. J.B. Chemicals & Pharmaceuticals Recent Development
Table 91. Jodas Expoim Corporation Information
Table 92. Jodas Expoim Description and Major Businesses
Table 93. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Jodas Expoim Product
Table 95. Jodas Expoim Recent Development
Table 96. Lantheus Medical Imaging Corporation Information
Table 97. Lantheus Medical Imaging Description and Major Businesses
Table 98. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Lantheus Medical Imaging Product
Table 100. Lantheus Medical Imaging Recent Development
Table 101. Nano Therapeutics Corporation Information
Table 102. Nano Therapeutics Description and Major Businesses
Table 103. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Nano Therapeutics Product
Table 105. Nano Therapeutics Recent Development
Table 106. Novalek Pharmaceuticals Corporation Information
Table 107. Novalek Pharmaceuticals Description and Major Businesses
Table 108. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Novalek Pharmaceuticals Product
Table 110. Novalek Pharmaceuticals Recent Development
Table 111. Taejoon Pharm Corporation Information
Table 112. Taejoon Pharm Description and Major Businesses
Table 113. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Taejoon Pharm Product
Table 115. Taejoon Pharm Recent Development
Table 116. Unijules Life Sciences Corporation Information
Table 117. Unijules Life Sciences Description and Major Businesses
Table 118. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Unijules Life Sciences Product
Table 120. Unijules Life Sciences Recent Development
Table 121. Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Region (2021-2026) (Million US$)
Table 122. Global Interventional X-ray Contrast and Imaging Agents Production Forecast by Regions (2021-2026) (K MT)
Table 123. Global Interventional X-ray Contrast and Imaging Agents Production Forecast by Type (2021-2026) (K MT)
Table 124. Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Type (2021-2026) (Million US$)
Table 125. North America Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Regions (2021-2026) (K MT)
Table 126. Europe Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Regions (2021-2026) (K MT)
Table 127. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Regions (2021-2026) (K MT)
Table 128. Latin America Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Regions (2021-2026) (K MT)
Table 129. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Regions (2021-2026) (K MT)
Table 130. Interventional X-ray Contrast and Imaging Agents Distributors List
Table 131. Interventional X-ray Contrast and Imaging Agents Customers List
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List of Figures
Figure 1. Interventional X-ray Contrast and Imaging Agents Product Picture
Figure 2. Global Interventional X-ray Contrast and Imaging Agents Production Market Share by Type in 2020 & 2026
Figure 3. Iodinated Contrast Media Product Picture
Figure 4. Barium-Based Contrast Media Product Picture
Figure 5. Microbubble Contrast Media Product Picture
Figure 6. Other Product Picture
Figure 7. Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application in 2020 & 2026
Figure 8. Heart Disease
Figure 9. Neurological
Figure 10. Urology
Figure 11. General Surgery
Figure 12. Other
Figure 13. Interventional X-ray Contrast and Imaging Agents Report Years Considered
Figure 14. Global Interventional X-ray Contrast and Imaging Agents Revenue 2015-2026 (Million US$)
Figure 15. Global Interventional X-ray Contrast and Imaging Agents Production Capacity 2015-2026 (K MT)
Figure 16. Global Interventional X-ray Contrast and Imaging Agents Production 2015-2026 (K MT)
Figure 17. Global Interventional X-ray Contrast and Imaging Agents Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 18. Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Interventional X-ray Contrast and Imaging Agents Production Share by Manufacturers in 2015
Figure 20. The Top 10 and Top 5 Players Market Share by Interventional X-ray Contrast and Imaging Agents Revenue in 2019
Figure 21. Global Interventional X-ray Contrast and Imaging Agents Production Market Share by Region (2015-2020)
Figure 22. Interventional X-ray Contrast and Imaging Agents Production Growth Rate in North America (2015-2020) (K MT)
Figure 23. Interventional X-ray Contrast and Imaging Agents Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 24. Interventional X-ray Contrast and Imaging Agents Production Growth Rate in Europe (2015-2020) (K MT)
Figure 25. Interventional X-ray Contrast and Imaging Agents Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 26. Interventional X-ray Contrast and Imaging Agents Production Growth Rate in China (2015-2020) (K MT)
Figure 27. Interventional X-ray Contrast and Imaging Agents Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 28. Interventional X-ray Contrast and Imaging Agents Production Growth Rate in Japan (2015-2020) (K MT)
Figure 29. Interventional X-ray Contrast and Imaging Agents Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 30. Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Regions 2015-2020
Figure 31. North America Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 32. North America Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application in 2019
Figure 33. North America Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Countries in 2019
Figure 34. U.S. Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 35. Canada Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 36. Europe Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 37. Europe Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application in 2019
Figure 38. Europe Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Countries in 2019
Figure 39. Germany Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 40. France Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 41. U.K. Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 42. Italy Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 43. Russia Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 44. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (K MT)
Figure 45. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application in 2019
Figure 46. Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Regions in 2019
Figure 47. China Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 48. Japan Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 49. South Korea Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 50. India Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 51. Australia Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 52. Taiwan Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 53. Indonesia Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 54. Thailand Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 55. Malaysia Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 56. Philippines Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 57. Vietnam Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 58. Latin America Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (K MT)
Figure 59. Latin America Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application in 2019
Figure 60. Latin America Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Countries in 2019
Figure 61. Mexico Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 62. Brazil Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 63. Argentina Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2015-2020) (K MT)
Figure 64. Middle East and Africa Interventional X-ray Contrast and Im

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs